RVX-308

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRVX-308
Drug Alias NameRVX-308
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesResverlogix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesResverlogix Corp
Active IndicationsN/A
Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksN/A